Heart Protection Study
This new research used data from the Heart Protection Study (HPS) is a landmark trial of simvastatin undertaken in 2005.
The HPS showed that when cheaper generic versions of statins are used, several years of treatment is cost-effective for a wide range of people with vascular disease or diabetes.
The HPS involved over 20,000 individuals with heart disease or diabetes. They were given either 40mg of simvastatin daily or placebo for five years.